L‐type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas
- 3 April 2009
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 99 (7) , 433-438
Abstract
Background: L‐type amino acid transporter 1 (LAT1) has been associated with tumor growth and is highly expressed in the primary human neoplasms. We investigated the significance of LAT1 expression to evaluate malignant potential in thymic epithelial tumors.Materials and Methods: Immunohistochemical studies of 45 surgically resected thymic epithelial tumors [15 noninvasive thymomas (NT), 22 invasive thymomas (IT), and 8 thymic carcinomas (TC)] were conducted. LAT1, Ki‐67 labeling index (LI), vascular endothelial growth factor (VEGF), and microvessel density of the thymic epithelial tumors were analyzed.Results: LAT1 expression for thymomas and thymic carcinomas were 0 (0%) of 37 and 6 (75%) of eight patients, respectively. Ki‐67 LI for NT, IT, and TC were 7.9 ± 2.8%, 16.1 ± 8.5%, and 50.6 ± 24.4%, respectively. VEGF expression in groups NT, IT, and TC was 0 (0%) of 15, 9 (41%) of 22, and 6 (75%) of eight patients, respectively. VEGF expression was statistically associated with microvessel count. The LAT1 expression was statistically associated with Ki‐67 LI, VEGF, and microvessel density in thymic carcinomas.Conclusion: LAT1 is frequently expressed in thymic carcinomas but is absent in thymomas. Our results suggest that LAT1 expression might be an immunohistochemical marker for carcinomas, and could distinguish between thymomas and thymic carcinomas. J. Surg. Oncol. 2009;99:433–438.Keywords
This publication has 28 references indexed in Scilit:
- Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancerBritish Journal of Cancer, 2008
- Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer: A Clinicopathologic StudyClinical Cancer Research, 2007
- CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasisLaboratory Investigation, 2006
- Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime?Seminars in Cancer Biology, 2005
- Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinomaJournal of Surgical Oncology, 2005
- Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB–IIA non-small cell lung cancerJournal of Clinical Pathology, 2004
- Proliferative Activity and Apoptosis in Thymic Epithelial NeoplasmsLaboratory Investigation, 2002
- Expression of a system L neutral amino acid transporter at the blood–brain barrierNeuroReport, 2000
- JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections.Journal of Clinical Pathology, 1990
- Evidence for two Types of Mediation of Neutral Amino-Acid Transport in Ehrlich CellsNature, 1963